BLUEBIRD STRATEGIES for MYOTONIC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Increasing funding for Myotonic Dystrophy research. Fiscal year 2019 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN KEVIN BRENNAN New | Chief of Staff, Rep. Rosa DeLauro (D-CT); Director, Rep. Sherrod Brown (D-OH); Legislative Assistant, Rep. Tom Foglietta (D-PA) |
Defense DEF
Increasing funding for Myotonic Dystrophy research. Fiscal year 2019 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN KEVIN BRENNAN New | Chief of Staff, Rep. Rosa DeLauro (D-CT); Director, Rep. Sherrod Brown (D-OH); Legislative Assistant, Rep. Tom Foglietta (D-PA) |
Medical/Disease Research/Clinical Labs MED
Increasing funding for Myotonic Dystrophy research. Fiscal year 2019 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN KEVIN BRENNAN New | Chief of Staff, Rep. Rosa DeLauro (D-CT); Director, Rep. Sherrod Brown (D-OH); Legislative Assistant, Rep. Tom Foglietta (D-PA) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.